JEOL (6951.T) Stock Price

JEOL Price

JPX·CLOSED
8,041.00
​
Market closed

Revenue has compounded at 3.0% per year over the past 19 years to 179.35 B JPY. Earnings per share have grown at 11.5% per year over the last 19 years. JEOL's net margin stands at 12.3%, up from 8.9% several years earlier. JEOL currently offers a dividend yield of about 2.09%. The payout ratio is around 24% of earnings. The dividend has grown at 12.8% per year over the past 19 years. Analysts set a median price target of 7,191.00 JPY, implying 10.6% below the current price. Of 10 analysts, 8 rate the stock a buy — an overall Buy consensus.

JEOL stock price

Access this data via the Eulerpool API

JEOL business model & stock analysis

JEOL Ltd is a Japanese company that was founded in 1949 and is now known worldwide as a leading manufacturer of scientific instruments. The company produces a wide range of products, including electron microscopes, mass spectrometers, NMR spectrometers, real-time PCR systems, scanning probe microscopes, and software solutions for scientific applications. JEOL Ltd's business model is based on the development and production of advanced technologies for science. The company is dedicated to the field of analytical instrumentation and invests continuously in research and development. JEOL Ltd aims to provide its customers with innovative instruments and services that deliver higher productivity, high quality, and fast results. One of the most well-known divisions of JEOL Ltd is the production of electron microscopes. The company offers a wide range of microscopes that can be used for diverse investigations and research. JEOL Ltd manufactures both transmission electron microscopes (TEM) and scanning electron microscopes (SEM), focusing on high resolution and specifications. In the recent past, the company introduced a new product line, the JEM-Z300FSC Super-Resolution Electron Microscope, which allows significant improvements in high-resolution sample imaging. JEOL Ltd is also a leading developer of mass spectrometers. These devices enable the analysis of materials for a variety of applications such as food safety testing, drug research, and environmental analysis. The company is known for innovative technological advancements such as the Large Chamber QMS with QUEDS technology, a high-performance mass spectrometer for specific analysis of gases and solids. Nuclear Magnetic Resonance (NMR) spectrometers are also an important component of JEOL Ltd's business. NMR spectroscopy allows for structural analysis of molecules in solution or in the solid state, which is essential for a wide range of research and development applications. JEOL Ltd has exceeded the boundaries of NMR spectroscopy technology through the introduction of ultrahigh-field NMR spectrometers for investigating solid-state materials at 1 GHz and continues to research tirelessly. The company is also involved in the production of real-time PCR systems. This technology enables rapid and accurate measurement of the amount of DNA in a sample, which is essential for diagnosis and research in the field of biology and medicine. JEOL Ltd has developed the PCR system X – Cite as the best technology for rapid examination of DNA sequences. Scanning probe microscopy is another important division of JEOL Ltd. This type of microscopy allows for the analysis of surface structures at the nanometer scale and is required for research on this extremely small scale. JEOL Ltd has achieved a leading position in the development and manufacture of these advanced systems. In addition to the aforementioned devices, JEOL Ltd also develops and distributes a variety of software codes for its products to better meet the needs of its customers. The products of JEOL Ltd are used in a wide range of industries and applications, including chemistry, pharmaceuticals, glass manufacturing, and the electronics industry. Overall, JEOL Ltd has achieved a leading position in scientific instrumentation worldwide through its relentless innovation and top-notch technical expertise. The company emphasizes its commitment to continuous development of new technologies to always provide its customers with the latest and most advanced solutions.

Frequently asked questions about JEOL

JEOL Ltd. is a Japanese company that specializes in manufacturing scientific and medical instruments. The business model of JEOL Ltd. revolves around producing and offering advanced scientific instruments, including electron microscopes, nuclear magnetic resonance (NMR) spectrometers, and mass spectrometers. By leveraging their expertise in research and development, JEOL Ltd. provides cutting-edge solutions for various scientific and industrial applications. Their products and services cater to a wide range of industries, including pharmaceuticals, biotechnology, materials science, and electronics. JEOL Ltd. focuses on innovation, quality, and customer satisfaction, thereby establishing itself as a trusted global leader in the scientific instrument industry.

JEOL Ltd is primarily active in the industries of scientific and analytical instruments.

The main competitors of JEOL Ltd in the market include Thermo Fisher Scientific, Hitachi High-Technologies Corporation, and Shimadzu Corporation. These companies also operate in the field of analytical instruments and high-end scientific equipment. JEOL Ltd competes with these industry leaders by leveraging its innovative product offerings, advanced technologies, and strong customer relationships. Through continuous research and development, JEOL Ltd aims to maintain its competitive edge and provide exceptional solutions for scientific research, industrial applications, and healthcare.

JEOL Ltd is a renowned company with a rich history and background. Established in 1949, JEOL has grown to become a global leader in the field of scientific instruments, particularly electron microscopes and analytical instruments. With a strong focus on research and development, the company continuously innovates to provide cutting-edge technologies to its customers. JEOL has an extensive presence worldwide and caters to a diverse range of industries, including materials science, life sciences, and nanotechnology. Known for its commitment to quality and customer satisfaction, JEOL Ltd maintains its position as a trusted provider of high-performance scientific solutions globally.

JEOL Ltd has achieved several significant milestones in its history. The company has established a strong reputation in the field of scientific and analytical instruments. Over the years, JEOL Ltd has made significant contributions to the advancement of electron microscopy technology and has developed cutting-edge instruments for imaging and analysis purposes. Additionally, the company has expanded its global presence and established strong partnerships with research institutions and industrial clients worldwide. With a commitment to innovation and high-quality products, JEOL Ltd continues to contribute to scientific advancements and remains a leading player in the industry.

JEOL Ltd is primarily present in various countries and regions around the world. The company has a strong global presence, with significant operations in Japan, where it is headquartered. In addition to its home market, JEOL Ltd has established a strong presence in other Asian countries such as China, South Korea, and Singapore. The company also has a significant presence in North America, particularly in the United States. Furthermore, JEOL Ltd has expanded its reach to European countries, including Germany, France, and the United Kingdom. With its widespread presence, JEOL Ltd is able to cater to a diverse range of customers and markets.

JEOL Ltd is a renowned company known for its exceptional values and corporate philosophy. Committed to innovation and excellence, JEOL Ltd aims to deliver cutting-edge technology and scientific instruments to its customers worldwide. With a strong focus on research and development, the company continuously strives to provide advanced solutions in the fields of electron microscopy, analytical instruments, and scientific equipment. JEOL Ltd prides itself on creating value for its stakeholders through integrity, teamwork, and customer satisfaction. By prioritizing sustainable growth and social responsibility, JEOL Ltd remains dedicated to enhancing the scientific community's progress and contributing to society's betterment.

Analysts currently set an average price target of 6,834.00 JPY for the JEOL stock (median: 7,191.00 JPY), implying -15.0 % versus the latest price. The consensus is based on 10 analyst ratings.

10 analysts currently rate the JEOL stock: 7 recommend buying, 3 holding and 0 selling.

Converted at the current exchange rate, the JEOL share trades at 45.44 EUR (8,041.00 JPY).

The JEOL share (6951.T) is listed on 2 stock exchanges, including: Tokio (JPX) (6951.T), Frankfurt (JEL.F).

JEOL Ltd. is a leading provider of scientific instruments based in Japan. The business model of JEOL focuses on the manufacturing and sale of scientific instruments in various industries such as microscopy, analytics, and semiconductor technology.

The revenue of JEOL is 179.35 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of JEOL is 22.10 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of JEOL is currently 17.72. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the JEOL stock.

The price-to-sales ratio (P/S) of JEOL is currently 2.18. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the JEOL stock.

The Eulerpool Quality Score for JEOL is 6/10.

The ISIN of JEOL is JP3735000006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of JEOL is 857766. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of JEOL is 6951.T. The ticker symbol is used to trade JEOL shares on the stock exchange.

Fair ValueTerminal
6,674.03 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
56.67 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website jeol.co.jp
Country
Currency
JPY
Initial public offering
Apr 5, 1962
ISIN
JP3735000006
Cusip
J23317100
Sedol
6470544
Market capitalization
411.09 B JPYMega Cap
52-Week Range
PEG
1.80
P/E ratio
P/Ee 2027
18.82
P/Ee 2028
15.57
P/Ee 2029
14.19
P/S
P/Se
2.30
EV/EBIT
15.34
P/B Ratio
2.84
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
12.85 %
Dividend
Dividend yield
2.09 %
Est. Dividend Yield
2.51 %
Payout Ratio
24.38 %
Dividend growth Ø5Y
20.55 %
Dividend payments per year
2
Dividend paid since
13 years
Dividend not reduced since
13 years
Dividend increased since
5 years
Dividend withholding tax
15.32 %
Last updated Oct 8, 2026, 10:19 PM

JEOL Ticker

FRANKFURT · JEL.FJPX · 6951.T

JEOL FIGI

6951:JP · BBG000BM3H076951:JT · BBG000BM3H896951:JJ · BBG000BM3PF36951:JE · BBG000BM3SH56951:JI · BBG000BM3SS3JEL:GR · BBG000BZGS55JEL:GF · BBG000BZGT71JEL:GB · BBG000BZGX09JELLF:US · BBG000D1GY73JELLF:PQ · BBG002JGWQT5JELLF:UV · BBG002JGWQW16951:JU · BBG002QK76C8

All fundamentals and in-depth analysis of JEOL

Our stock analysis for JEOL stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of JEOL. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.